AzTrials
AzTrials

Medical DeviceNCT04006899

Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement

An observational study of Medical Device, run by Jun Choi at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A device for measuring body composition with a small electric current, at 200 μA, (bioelectrical impedance analysis, or BIA) was designed. The goal of this study is to validate the device against several existing devices using the same method of measuring body composition with a small electric current. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Medical Device
What is being tested?
Bioelectrical Impedance Monitor
Type of treatment
Medical device
How many people
5 participants
Where
1 siteUnited States
Study dates
20 Jun 2018to 30 May 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Students from Georgia Southern University

Who may be able to join

  • Students from Georgia Southern University

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Georgia Southern University

    Statesboro, Georgia, 30459

Other trials in United States

About this study

A device for measuring body composition with a small electric current, at 200 μA, (bioelectrical impedance analysis, or BIA) was designed. The goal of this study is to validate the device against several existing devices using the same method of measuring body composition with a small electric current.

Read the detailed description

The measurement of individual segments, instead of the body as a whole, with BIA has not been fully explored. The prototype device is capable of directly measuring multiple body segments (arm, trunk, and leg) simultaneously, and the final version will be able to provide composition about each segment and the body as a whole. Current devices on the market are not capable of this.

The reference devices will be used to measure segments as well, and the raw measurements will be compared. The Multiscan 5000 provides segmental body composition for the arm or leg, but requires measuring it separately. The SFB7 is designed only for measuring the whole body, but the raw impedance measurement data from the SFB7 can be used for comparison, as the impedance magnitudes of individual segments will be within its measurement range. The Seca 514 doesn't directly measure segments, but it can provide segmental data by measuring from hand to foot, then from hand to hand, and finally from foot to foot. It then uses these measurements, and assumptions about the subject to provide segmental composition data.

Conditions
Medical Device
Being tested
Bioelectrical Impedance Monitor
Keywords
Bioelectrical Impedance spectroscopy, Body compositions, Segmental Bioelectrical impedance spectroscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Bioelectrical Impedance MonitorDevice

    Subjects had been under the test of three commercially available devices and the device that the investigators had developed.

Study groups in NCT04006899
Study groupRoleWhat they receive
subj 1Three commercially available BIA devices vs SBIS device
Receives: Device: Bioelectrical Impedance Monitor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Impedance values from each devices

    Bioelectrical impedance values from three devices were measured and recorded.

    Measured: One year IRB period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jul 2019
  2. Study start20 Jun 2018
  3. Primary completion30 May 2019
  4. Study completion30 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
5 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04006899
Sponsor's protocol ID
GSU001
Status last verified
Jul 2019
First submitted
28 Jun 2019
Last updated
5 Jul 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Medical Device, run by Jun Choi at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Impedance values from each devices (time frame: One year IRB period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in